Labeling Based On Consumer Comprehension Data Stressed By McClellan
This article was originally published in The Tan Sheet
Executive Summary
Empirical data on consumer comprehension of food and drug labeling would play a prominent role in FDA rulemaking if the Senate confirms White House economic advisor Mark McClellan, MD/PhD, as the agency's new commissioner
You may also be interested in...
FDA Consumer Health Information Task Force To Be Chaired By Crawford
A new FDA task force will propose a research agenda focused on determining how science-based nutrition information is best articulated to consumers, Commissioner Mark McClellan, MD/PhD, announced Dec. 18
FDA Commissioner McClellan
White House health and economic advisor Mark McClellan, MD/PhD, unanimously confirmed by Senate Oct. 17 after Health Committee member Jeff Bingaman (D-N.M.) lifted hold on nomination (1"The Tan Sheet" Oct. 14, 2002, p. 7). Confirmation comes 21 months after former Commissioner Jane Henney, MD, left office. Although no swearing-in date had been set as of Oct. 18, FDA's Science Board meeting in Rockville, Md. Oct. 25 could mark his first public appearance as commissioner. Meeting agenda lists introductory remarks to be given by McClellan "pending confirmation." Meeting will include discussion of CFSAN counterterrorism efforts, CDER's drug GMP initiative...
Dietary Supplement GMPs Could Lean Toward Drug Model, Troy Hints
FDA's proposed rule on dietary supplement Good Manufacturing Practices could more closely follow the pharmaceutical GMPs model than would be preferred by the supplement industry